乙醇胺用于预防REM睡眠呼吸暂停的呼吸器驱动:一个随机对照试验
Ludovico Messineo1, Molly Kim2, Ali Azarbarzin2
1Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, Massachusetts, USA ludovico.messineo@yahoo.it.
Thorax
|March 4, 2026
概括
乙胺改善了REM睡眠中的阻塞性睡眠呼吸暂停 (OSA) 严重程度,通过减少气道缩性和改善肌肉反应能力,尽管它没有解决通风驱动的潜在下降.
科学领域:
- 睡眠医学 睡眠医学
- 呼吸系统生理学 呼吸系统生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在REM睡眠期间阻塞性睡眠呼吸暂停 (OSA) 与呼吸器驱动力降低和神经的肌肉低血压有关.
- 已知一种碳酸胺酶抑制剂阿扎胺可增强通风驱动和改善OSA.
- 这项研究研究了乙胺对REM占主导地位的OSA及其生理机制的影响.
研究的目的:
- 评估乙胺在降低REM占主导地位的OSA患者的呼吸暂停 (apnoea hypopnoea index (AHI)) 和缺氧负担方面的疗效.
- 阐明阿西塔佐拉米德在REM睡眠期间影响呼吸机驱动,通风和喉肌肉活动的生理机制.
主要方法:
- 一项随机,交叉,双盲研究,涉及11名REM主导的OSA参与者.
- 参与者接受了阿西塔佐胺 (500毫克) 或安慰剂三晚,一个星期的洗期.
- 在每次干预后,都进行了详细的透视视镜与腹膜和光体电肌图.
主要成果:
- 与安慰剂相比,乙胺显著降低了AHI35.5%,低氧负担降低了35.9% (p<0.001).
- 意想不到的是,阿西塔佐拉米德并没有缓解REM睡眠期间呼吸器驱动力的下降.
- 乙胺增加了eupneic驱动器的通风,表明上呼吸道缩性降低,并增强了神经的肌肉反应能力.
结论:
- 乙胺通过增强上呼吸道生理学,在REM占主导地位的OSA中提供了适度的改善.
- 这种药物有效地减少了气道的折叠性,并改善了肌肉的反应能力.
- 乙醇胺未能缓解呼吸机驱动的下降表明它没有解决REM OSA的主要原因.
关键词:
睡眠呼吸暂停 睡眠呼吸暂停更多相关视频
09:06Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
10.1K
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
11.6K
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
981
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
981
Mechanical Ventilation III: Noninvasive Ventilation
931
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
931
REM Sleep Behavior Disorder
2.9K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.9K
Sleep Apnea
914
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
914
